As of March 2024 Nectar Lifesciences has a market cap of $81.15 Million. This makes Nectar Lifesciences the world's 7519th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $81.15 M | -6.5% |
2023 | $86.79 M | 30.44% |
2022 | $66.54 M | -17.75% |
2021 | $80.89 M | 10.15% |
2020 | $73.44 M | 92.52% |
2019 | $38.14 M | -42.12% |
2018 | $65.9 M | -51.48% |
2017 | $0.13 B | 25.06% |
2016 | $0.10 B | -40.45% |
2015 | $0.18 B | 46.86% |
2014 | $0.12 B | 83.46% |
2013 | $67.69 M | -21.1% |
2012 | $85.8 M | 22.9% |
2011 | $69.81 M | -55.22% |
2010 | $0.15 B | 46.18% |
2009 | $0.10 B | 81.98% |
2008 | $58.6 M | -48.23% |
2007 | $0.11 B | 107.31% |
2006 | $54.6 M | -23.96% |
2005 | $71.81 M |
On Mar 28th, 2024 the market cap of Nectar Lifesciences was reported to be: